Trademark: 97122963
Word
THERALY
Status
Pending
Status Code
731
Status Date
Friday, November 10, 2023
Serial Number
97122963
Mark Type
4000
Filing Date
Friday, November 12, 2021
Published for Opposition
Tuesday, September 27, 2022
Trademark Owner History
Theraly Fibrosis, Inc. - Owner At Publication
Classifications
5 Pharmaceuticals for the treatment of fibrotic diseases, chronic pancreatitis, systemic sclerosis, nonalcoholic steatohepatitis (NASH); pharmaceuticals for the treatment of oncology, diabetes, obesity, and ocular, metabolic, central nervous system and immune systems diseases and disorders
Trademark Events
Nov 14, 2023
Notice Of Approval Of Extension Request E-Mailed
Nov 10, 2023
Sou Extension 2 Granted
Nov 10, 2023
Sou Extension 2 Filed
Nov 10, 2023
Sou Teas Extension Received
May 17, 2023
Notice Of Approval Of Extension Request E-Mailed
May 15, 2023
Sou Extension 1 Granted
May 15, 2023
Sou Extension 1 Filed
May 15, 2023
Sou Teas Extension Received
Nov 22, 2022
Noa E-Mailed - Sou Required From Applicant
Sep 27, 2022
Official Gazette Publication Confirmation E-Mailed
Sep 27, 2022
Published For Opposition
Sep 7, 2022
Notification Of Notice Of Publication E-Mailed
Aug 23, 2022
Approved For Pub - Principal Register
Aug 23, 2022
Assigned To Examiner
Nov 19, 2021
New Application Office Supplied Data Entered
Nov 16, 2021
New Application Entered
KAZURA
TDSQL-H LIBRADB
Trademark Alertz updated from USPTO on 2030-01-24

Trademark Alertz ™ - GRJR PTY LTD 2024 - Privacy Policy - Terms of Use

The information provided on Trademark Alertz is not legal or professional advice. Information may have been obtained from third parties and may contain errors. You must make your own enquiries and seek independent advice from relevant industry professionals before acting or relying on any information from Trademark Alertz. All trade mark information has been obtained from and made publicly available by The United States Patent and Trademark Office (USPTO). Copyright of the trademark data resides with USPTO. www.uspto.gov